Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Taohong Tongluo Xiaoban Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients：a Randomized Controlled Clinical Trial

NCT06549582 is registered in ClinicalTrials.gov with Yan Zhu as lead sponsor.

NCT NCT06549582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06549582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Taohong Tongluo Xiaoban Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients：a Randomized Controlled Clinical Trial
Lead sponsor
Yan Zhu
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
December 31, 2026
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction, chinese herbal medicine, clinical trial, endothelial injury, lipid metabolism disorder